Pivagabine: a novel psychoactive drug.

Autor: Esposito G; Aziende Chimiche Riunite Angelini Francesco S.p.A. (ACRAF S.p.A.), Medical Department, Rome, Italy., Luparini MR
Jazyk: angličtina
Zdroj: Arzneimittel-Forschung [Arzneimittelforschung] 1997 Nov; Vol. 47 (11A), pp. 1306-9.
Abstrakt: Pivagabine (4-[(2,2-dimethyl-1-oxopropyl)amino]butanoic acid, CAS 69542-93-4, Tonerg) is a metabolically stable compound with a modulatory effect on some biochemical parameters involved in stress conditions (corticotropin releasing factor, neurosteroids). The compound, tested in several animal models, prevents stress-correlated behavioural deficits. Moreover, pivagabine has a highly significant therapeutic potential in clinical conditions characterized by manifestations of psychological distress due to an inadequate management of stressful events.
Databáze: MEDLINE